Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Icoria Inc.

Division of Allergan PLC
icoria.com

Latest From Icoria Inc.

Biomarkers for Psychiatric Drugs: Outlier or Opportunity?

A handful of companies are pursuing predictive genetic tests for evaluating psychiatric drugs. The need is apparent, and an early success could trigger a rapid shift in thinking about the sustainability of building a business around biomarkers in a therapeutic area sometimes considered the least likely to benefit near term from their development. That said, firms in this area--and elsewhere--must be wary of leaning too heavily on pharma companies as supportive partners.
BioPharmaceutical Medical Device

StemCo Biomedical Inc.

StemCo Biomedical believes it has technologies that will increase the efficiency and effectiveness of stem cell transplantation, addressing and expanding an existing market. The company hopes that, in the long term, an effective stem cell transplantation therapy will reach new patient populations, for example, sufferers of autoimmune diseases. For the near term, however, the company is keeping focused on getting onto the research market products that demonstrate its particular expertise; the identification and selection of viable stem cells.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Hepatic (Liver)
  • Metabolic Disorders
  • Alias(es)
  • Paradigm Genetics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Douglas R Morton, PhD, Interim CEO
    Thomas J Colatsky, PhD, CSO
    Brett Farabaugh, VP, Fin.
  • Contact Info
  • Icoria Inc.
    Phone: (919) 425-3000
    108 Alexander Dr.
    Bldg. 2
    P.O. Box 14528 Research Triangle Park, NC 27709-4528
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register